Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |